Clinical Report: Digital Pathology: the Great Translation Debate

Overview

The Transforming Digital Pathology and AI conference highlighted the transition towards digital pathology, emphasizing the need for practical implementation in clinical settings. Key challenges include staffing shortages, siloed systems, and the integration of AI as a supportive tool rather than a replacement for pathologists.

Background

Digital pathology is becoming increasingly vital as laboratories face rising workloads and staffing challenges. The integration of AI tools aims to enhance operational efficiency and diagnostic accuracy. However, successful adoption hinges on overcoming cultural, operational, and financial barriers within the pathology community.

Data Highlights

No numerical data was provided in the source material.

Key Findings

• AI is viewed as a supportive tool to assist pathologists rather than a replacement.
• Staffing shortages and workforce burnout are prevalent issues in pathology laboratories.
• Siloed systems hinder operational performance and clinical efficiency.
• Cost and lack of infrastructure are significant barriers to the adoption of digital pathology and AI.
• Future generations of pathologists may prefer laboratories with modern digital infrastructure.

Clinical Implications

Pathologists and laboratory leaders should prioritize the integration of digital tools to enhance workflow efficiency. Continuous training and workforce capacity are essential to ensure successful adoption of digital pathology technologies.

Conclusion

Highlight the need to address barriers in the implementation of digital pathology.

Related Resources & Content

1. The Pathologist, 2026 -- Digital Pathology: Who’s Leading?
2. The Pathologist, 2026 -- Going Digital in Community Pathology
3. The Pathologist, 2026 -- The Future of Subspecialization in Pathology
4. The Pathologist, 2026 -- Digital Technology Is Ready. Are We?
5. College of American Pathologists -- Validating Whole Slide Imaging for Diagnostic Purposes in Pathology
6. FDA, July 31, 2025 -- De Novo authorization to ArteraAI Prostate
7. Surgical and Experimental Pathology -- Artificial intelligence in histopathology and cytopathology: an umbrella review of systematic reviews and meta-analyses
8. Validating Whole Slide Imaging for… | College of American Pathologists
9. July 31, 2025
10. Artificial intelligence in histopathology and cytopathology: an umbrella review of systematic reviews and meta-analyses | Surgical and Experimental Pathology | Springer Nature Link